Vanguard Global Advisers’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24M Buy
330,535
+6,445
+2% +$464K 0.01% 542
2026
Q2
$22.9M Sell
324,090
-6,410
-2% -$346K 0.01% 549
2026
Q1
$17.3M Buy
+330,500
New +$19.8M 0.01% 571

Other funds holding TECH

Vanguard Global Advisers's TECH Position: Q3 2026 in Review

Vanguard Global Advisers increased its Bio-Techne (TECH) stake by 2% in Q3 2026, buying an estimated $464K and bringing the position to 330,535 shares worth $24M. The position accounts for 0.01% of the portfolio, ranked #542.

Vanguard Global Advisers first reported a position in TECH in Q1 2026 and has held it in 3 quarters since. 581 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Vanguard Global Advisers held 330,535 shares of Bio-Techne worth $24M as of Q3 2026.
  • Vanguard Global Advisers bought 6,445 Bio-Techne shares in Q3 2026, an estimated $464K.
  • Bio-Techne made up 0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #542 holding.
  • Vanguard Global Advisers first reported a position in Bio-Techne in Q1 2026 and has held it in 3 quarters since.
  • 581 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.